Name: Neal Bhatia, MD: Ritlecitinib as an Emerging Therapy for Alopecia Areata
Uploaded: 2023-01-25T05:00:00+00:00
Description: Dr. Bhatia details the recent approval of Ritlecitinib which is launching soon for the treatment of alopecia areata.

Dr. Bhatia discusses ritlecitinib, a JAK3/TEC inhibitor currently in trials for the treatment of alopecia areata.

JCAD

Journal of Clinical and Aesthetic Dermatology

JCAD Archives